Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)
CUSIP: 45258J102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 202,731,676
- Total 13F shares
- 96,203,927
- Share change
- +1,939,127
- Total reported value
- $1,539,273,430
- Put/Call ratio
- 120%
- Price per share
- $16.00
- Number of holders
- 167
- Value change
- +$25,954,256
- Number of buys
- 95
- Number of sells
- 96
Quarterly Holders Quick Answers
What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45258J102:
Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
8.5%
|
17,241,035
|
$294,649,289 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
13D/G
|
Company |
5.6%
from 13D/G
|
9,500,000
|
$162,355,000 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.4%
|
6,936,859
|
$118,550,920 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.9%
|
5,894,824
|
$100,743,000 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
2.7%
|
5,457,881
|
$93,275,186 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
2.6%
|
5,364,222
|
$91,674,553 | — | 31 Mar 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
2.2%
|
4,500,000
|
$76,905,000 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
3,087,095
|
$52,758,454 | — | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
1.4%
|
2,844,072
|
$48,605,190 | — | 31 Mar 2025 | |
| Alpine Global Management, LLC |
13F
|
Company |
1.3%
|
2,626,692
|
$44,890,166 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.83%
|
1,672,590
|
$28,592,303 | — | 31 Mar 2025 | |
| Two Seas Capital LP |
13F
|
Company |
0.81%
|
1,642,772
|
$28,074,973 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.74%
|
1,497,869
|
$25,598,581 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.65%
|
1,310,050
|
$22,388,754 | — | 31 Mar 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.59%
|
1,188,578
|
$20,312,798 | — | 31 Mar 2025 | |
| Hood River Capital Management LLC |
13F
|
Company |
0.58%
|
1,175,863
|
$20,095,499 | — | 31 Mar 2025 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
0.55%
|
1,114,827
|
$19,052,393 | — | 31 Mar 2025 | |
| Peter Salzmann |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
1,552,586
mixed-class rows
|
$17,543,264 | — | 16 Apr 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.5%
|
1,007,700
|
$17,221,593 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.48%
|
975,803
|
$16,676,473 | — | 31 Mar 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.48%
|
968,866
|
$16,557,920 | — | 31 Mar 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.42%
|
853,472
|
$14,585,836 | — | 31 Mar 2025 | |
| Julia G. Butchko |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
509,682
mixed-class rows
|
$14,251,795 | — | 21 Aug 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.4%
|
819,477
|
$14,004,862 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.4%
|
801,927
|
$13,704,939 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.38%
|
760,608
|
$12,998,791 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.37%
|
744,544
|
$12,725,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.36%
|
731,853
|
$12,507,367 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.32%
|
652,719
|
$11,154,967 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.31%
|
626,612
|
$10,708,799 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
536,622
|
$9,170,870 | — | 31 Mar 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.24%
|
490,394
|
$8,380,833 | — | 31 Mar 2025 | |
| Mark S. Levine |
3/4/5
|
Chief Legal Officer |
—
mixed-class rows
|
387,951
mixed-class rows
|
$8,124,353 | — | 20 Nov 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.23%
|
471,961
|
$8,065,812 | — | 31 Mar 2025 | |
| William L. Macias |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
426,076
mixed-class rows
|
$7,454,384 | — | 19 Feb 2025 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.21%
|
430,000
|
$7,348,700 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.2%
|
411,509
|
$7,032,689 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.2%
|
395,900
|
$6,765,931 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.19%
|
394,936
|
$6,751,245 | — | 31 Mar 2025 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.18%
|
375,000
|
$6,408,750 | — | 31 Mar 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.18%
|
364,229
|
$6,224,674 | — | 31 Mar 2025 | |
| Prosight Management, LP |
13F
|
Company |
0.18%
|
360,000
|
$6,152,400 | — | 31 Mar 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.17%
|
350,000
|
$5,981,500 | — | 31 Mar 2025 | |
| Eva Renee Barnett |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
521,954
mixed-class rows
|
$5,907,965 | — | 16 Apr 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.16%
|
327,825
|
$5,602,529 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.14%
|
289,329
|
$4,944,632 | — | 31 Mar 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.14%
|
275,000
|
$4,699,750 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.12%
|
233,985
|
$3,998,804 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
201,911
|
$3,450,658 | — | 31 Mar 2025 | |
| Jump Financial, LLC |
13F
|
Company |
0.1%
|
200,835
|
$3,432,270 | — | 31 Mar 2025 |
Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2025
As of 30 Jun 2025,
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by
167 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
96,203,927 shares.
The largest 10 holders included
FMR LLC, Deep Track Capital, LP, VANGUARD GROUP INC, T. Rowe Price Investment Management, Inc., BlackRock, Inc., BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, Point72 Asset Management, L.P., STATE STREET CORP, and Alpine Global Management, LLC.
This page lists
167
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
191
Q2 2025 holders
167
Holder diff
-24
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.